Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Days Sales Outstanding : 91.25 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Chongqing Genrix Biopharmaceutical Co Days Sales Outstanding?

Chongqing Genrix Biopharmaceutical Co's average Accounts Receivable for the three months ended in Mar. 2024 was ¥0.01 Mil. Chongqing Genrix Biopharmaceutical Co's Revenue for the three months ended in Mar. 2024 was ¥0.01 Mil. Hence, Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 91.25.

The historical rank and industry rank for Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding or its related term are showing as below:

SHSE:688443' s Days Sales Outstanding Range Over the Past 10 Years
Min: 5.88 Med: 108.79 Max: 211.69
Current: 15.36

During the past 5 years, Chongqing Genrix Biopharmaceutical Co's highest Days Sales Outstanding was 211.69. The lowest was 5.88. And the median was 108.79.

SHSE:688443's Days Sales Outstanding is ranked better than
92.96% of 881 companies
in the Biotechnology industry
Industry Median: 72.66 vs SHSE:688443: 15.36

Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding declined from Mar. 2023 (97.64) to Mar. 2024 (91.25).

Chongqing Genrix Biopharmaceutical Co Days Sales Outstanding Historical Data

The historical data trend for Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chongqing Genrix Biopharmaceutical Co Days Sales Outstanding Chart

Chongqing Genrix Biopharmaceutical Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

211.69

5.88

Chongqing Genrix Biopharmaceutical Co Quarterly Data
	Dec19	Dec20	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial								97.64	186.65	425.83	-	91.25

Competitive Comparison of Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding

For the Biotechnology subindustry, Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding falls into.

Chongqing Genrix Biopharmaceutical Co Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	1.212	*	365
=	0					/	1.212	*	365
=	0.00

Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0	+	0.006)	/	1 )	/	0.006	*	365 / 4
=	0.006					/	0.006	*	365 / 4
=	91.25

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Chongqing Genrix Biopharmaceutical Co Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Chongqing Genrix Biopharmaceutical Co's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chongqing Genrix Biopharmaceutical Co Ltd (SHSE:688443) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 699, Maliu Avenue, Area A, Building 2, International Bio City, Banan, Chongqing, CHN, 401338

Website

http://www.genrixbio.com

Chongqing Genrix Biopharmaceutical Co Ltd is engaged in the research & development, production and sales of antibody drugs. The company has a total of more than ten products under research covering three major therapeutic areas. The progress of core products is leading, and some product pipelines are as follows; autoimmune disease, infectious disease, and tumor. Its product Xeligekimab injection (Xeligekimab) is a recombinant fully human anti-IL-17A monoclonal antibody independently developed by the company, which has been accepted by the National Medical Products Administration (NMPA) for new drug marketing applications.

Executives

Jiang Ren Sheng

Director

Chongqing Genrix Biopharmaceutical Co (SHSE:688443) Headlines

No Headlines